Oleksandr Brener

发表

Correction: Competitive Mirror Image Phage Display Derived Peptide Modulates Amyloid Beta Aggregation and Toxicity

C. Teunissen, D. Willbold, L. Gremer, 2016, PloS one.

In Vitro Potency and Preclinical Pharmacokinetic Comparison of All-D-Enantiomeric Peptides Developed for the Treatment of Alzheimer’s Disease

K. Langen, N. Shah, D. Willbold, 2018, Journal of Alzheimer's disease : JAD.

Immobilization of Homogeneous Monomeric, Oligomeric and Fibrillar Aβ Species for Reliable SPR Measurements

F. Oesterhelt, D. Willbold, J. Glück, 2014, PloS one.

QIAD assay for quantitating a compound’s efficacy in elimination of toxic Aβ oligomers

Ewa A. Mirecka, A. Janssen, T. van Groen, 2015, Scientific Reports.

Double-strand DNA end-binding and sliding of the toroidal CRISPR-associated protein Csn2

Holger Gohlke, Rolf Wagner, Sander H. J. Smits, 2013, Nucleic acids research.

Competitive Mirror Image Phage Display Derived Peptide Modulates Amyloid Beta Aggregation and Toxicity

C. Teunissen, D. Willbold, L. Gremer, 2016, PloS one.

Identification and characterization of an aβ oligomer precipitating peptide that may be useful to explore gene therapeutic approaches to Alzheimer disease.

D. Willbold, Hongmei Liu, K. Wiesehan, 2012, Rejuvenation research.

Oral treatment with the d-enantiomeric peptide D3 improves the pathology and behavior of Alzheimer's Disease transgenic mice.

Anselm H. C. Horn, T. van Groen, G. Schoehn, 2010, ACS chemical neuroscience.

A d-enantiomeric peptide interferes with heteroassociation of amyloid-β oligomers and prion protein

D. Willbold, L. Gremer, H. Heise, 2018, The Journal of Biological Chemistry.

The Aβ oligomer eliminating D-enantiomeric peptide RD2 improves cognition without changing plaque pathology

T. van Groen, I. Kadish, D. Willbold, 2017, Scientific Reports.

Optimization of d-Peptides for Aβ Monomer Binding Specificity Enhances Their Potential to Eliminate Toxic Aβ Oligomers.

T. van Groen, I. Kadish, D. Willbold, 2017, ACS Chemical Neuroscience.

Large-Scale Oral Treatment Study with the Four Most Promising D3-Derivatives for the Treatment of Alzheimer’s Disease

D. Willbold, B. Hutter-Paier, Markus Tusche, 2017, Molecules.

Increase of Positive Net Charge and Conformational Rigidity Enhances the Efficacy of d-Enantiomeric Peptides Designed to Eliminate Cytotoxic Aβ Species.

T. van Groen, I. Kadish, D. Willbold, 2016, ACS chemical neuroscience.

The Aβ oligomer eliminating D-enantiomeric peptide RD2 improves cognition without changing plaque pathology

T. van Groen, I. Kadish, D. Willbold, 2017, Scientific Reports.

Optimization of the All-D Peptide D3 for Aβ Oligomer Elimination

E. Wanker, A. Boeddrich, J. Buitenhuis, 2016, PloS one.

Progress towards structural understanding of infectious sheep PrP-amyloid

G. Legname, O. Andréoletti, D. Willbold, 2014, Prion.

Optimization of the All-D Peptide D3 for Aβ Oligomer Elimination

E. Wanker, A. Boeddrich, J. Buitenhuis, 2016, PloS one.

Combining independent drug classes into superior, synergistically acting hybrid molecules.

Anselm H. C. Horn, K. Reymann, G. Schoehn, 2010, Angewandte Chemie.

A D -enantiomeric peptide interferes with heteroassociation of amyloid- (cid:2) oligomers and prion protein

L. Gremer, H. Heise, W. Hoyer, 2018 .

Optimization of d-Peptides for Aβ Monomer Binding Specificity Enhances Their Potential to Eliminate Toxic Aβ Oligomers.

T. van Groen, I. Kadish, D. Willbold, 2017, ACS chemical neuroscience.